This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Options trading offers unique opportunities to boost investment returns. Discover how to leverage options for greater gains.
25,570 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
The nuclear energy sector is staging a comeback. This article breaks down two top stock ideas, explains why they matt...
A renowned artist and philanthropist reveals a different dream: winemaking. This article turns that tale into practic...
Private markets are stuck in a funding logjam, with longer waiting times and shrinking payouts, signaling that the ci...
As companies rush to deploy AI, hundreds of pilots risk wasting resources and diluting strategy. Analysts warn that t...
Two Nasdaq-100 trackers offer the same index path, but a small fee delta has produced a 6.86% trailing return gap ove...
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...
Virginia’s starting question whether its data-center incentives are delivering broad value has moved into a high-stak...
Kestra Medical (KMTS) is in focus as Q3 2026 results hit the tape. This article breaks down what the transcript revea...
Riding the wave of sensational headlines can derail your money plans. This guide shows how to keep your finances stea...
Microsoft is weighing a billion-dollar investment in OpenAI, with talks centering on a possible up-to-10-billion plan...
WeRide (WRD) is navigating growth with ride-hailing, delivery, and autonomous tech. This Q1 2026 earnings-focused ana...